Effectiveness and safety of opioids on breathlessness and exercise endurance in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis of randomised controlled trials

医学 荟萃分析 不利影响 恶心 物理疗法 随机对照试验 慢性阻塞性肺病 内科学
作者
Meilu Liu,Wei Xiao,Longyi Du,Yan Yu,Xugui Chen,Bing Mao,Juan Fu
出处
期刊:Palliative Medicine [SAGE Publishing]
卷期号:37 (9): 1365-1378 被引量:6
标识
DOI:10.1177/02692163231194838
摘要

Background: Opioids are recommended to treat advanced refractory dyspnoea despite optimal therapy by the American Thoracic Society clinical practice guidelines, while newly published randomised controlled trials of opioids in chronic obstructive pulmonary disease yield conflicting results. Aim: This study aimed to evaluate the effectiveness and safety of opioids for patients with chronic obstructive pulmonary disease. Design: Systematic review and meta-analysis (PROSPERO CRD42021272556). Data sources: Databases of PubMed, EMBASE and CENTRAL were searched from inception to 2022 for eligible randomised controlled trials. Results: Twenty-four studies including 975 patients, were included. In cross-over studies, opioids improved breathlessness (standardised mean difference, −0.43; 95% CI, −0.55 to −0.30; I 2 = 18%) and exercise endurance (standardised mean difference, 0.22; 95% CI, 0.02–0.41; I 2 = 70%). However, opioids failed to improve dyspnoea (standardised mean difference, −0.02; 95% CI, −0.22 to 0.19; I 2 = 39%) and exercise endurance (standardised mean difference, 0.00; 95% CI, −0.27 to 0.27; I 2 = 0%) in parallel control studies that administered sustained-release opioids for more than 1 week. The opioids used in most crossover studies were short-acting and rarely associated with serious adverse effects. Only minor side effects such as dizziness, nausea, constipation and vomiting were identified for short-acting opioids. Conclusions: Sustained-release opioids did not improve dyspnoea and exercise endurance. Short-acting opioids appeared to be safe, have potential to lessen dyspnoea and improve exercise endurance, supporting benefit in managing episodes of breathlessness and providing prophylactic treatment for exertional dyspnoea.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Nole的应助被科研通管家采纳,获得30
刚刚
情怀的应助被无问西东采纳,获得10
刚刚
共享精神的应助被科研通管家采纳,获得10
刚刚
勤奋一一的应助被科研通管家采纳,获得10
刚刚
在水一方的应助被科研通管家采纳,获得10
刚刚
小马甲的应助被科研通管家采纳,获得10
刚刚
天天快乐的应助被科研通管家采纳,获得10
刚刚
情怀的应助被科研通管家采纳,获得10
刚刚
369ninja的应助被科研通管家采纳,获得10
1秒前
勤奋一一的应助被科研通管家采纳,获得10
1秒前
李健的应助被科研通管家采纳,获得10
1秒前
晓晓完成签到,获得积分10
1秒前
平常迎天发布了新的文献求助20
1秒前
科目三的应助被科研通管家采纳,获得10
1秒前
顾矜的应助被科研通管家采纳,获得10
1秒前
田様的应助被科研通管家采纳,获得10
1秒前
1秒前
英姑的应助被科研通管家采纳,获得10
1秒前
隐形曼青的应助被科研通管家采纳,获得10
2秒前
小蘑菇的应助被科研通管家采纳,获得10
2秒前
2秒前
zzzz完成签到,获得积分10
2秒前
yyy完成签到,获得积分10
2秒前
小蘑菇的应助被科研通管家采纳,获得10
2秒前
大个的应助被科研通管家采纳,获得10
2秒前
2秒前
思源的应助被科研通管家采纳,获得10
2秒前
田様的应助被科研通管家采纳,获得10
2秒前
2秒前
orixero的应助被科研通管家采纳,获得10
2秒前
深情安青的应助被科研通管家采纳,获得10
3秒前
科研通AI2S的应助被科研通管家采纳,获得10
3秒前
5秒前
充电宝的应助被dyh采纳,获得10
5秒前
傲娇的鹰完成签到,获得积分10
6秒前
虚心碧完成签到,获得积分10
6秒前
andjdd完成签到,获得积分10
7秒前
123发布了新的文献求助10
7秒前
隐形曼青的应助被刘先生采纳,获得10
8秒前
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8182014
求助须知:如何正确求助?哪些是违规求助? 9571728
关于积分的说明 21819478
捐赠科研通 7778441
什么是DOI,文献DOI怎么找? 3433580
关于科研通互助平台的介绍 2557781
邀请新用户注册赠送积分活动 2479640